Skip to content

2016 Hepatitis C Virus (HCV) Update

  • Chad Cipiti

July 15, 2016 By Mark Harrington Due to recent transitions in the TAG HCV Project [1], we did not complete a comprehensive update on hepatitis C virus (HCV) pipeline. Here are a few highlights in HCV regulation, access, and policy…

Read more

Hepatitis C Treatment Access: Spotlight on Thailand/Asia

  • Chad Cipiti

July 2012 By Karyn Kaplan According to the Universal Declaration of Human Rights and subsequent treaties, all people have a fundamental right to the highest attainable standard of health, as well as a right to the benefits of scientific progress…

Read more

Hepatitis C Drug Development Update from AASLD

  • Chad Cipiti

December 2012 By Tracy Swan It is difficult to be anything other than dazzled by astounding cure rates of up to 100% from a multitude of interferon-free hepatitis C virus (HCV) clinical trials presented at the American Association for the…

Read more

HCV Fact Sheets

  • Chad Cipiti
Fact sheets in English and Spanish covering adherence, hepatitis c diagnostics, hcv genotypes, sofosbuvir/daclatasvir, Mavyret, Solvaldi, Olysio, Vekira XR and Technivie, Harvoni, Daklinza, Zepatier, Epclusa, Ribavirin, and Hepatitis C and the IL28B gene.
Read more

EATAN HIV/AIDS & Hepatitis C Community Summit Report

  • Chad Cipiti

In July, 2018, The European African Treatment Advocates Network (EATAN), in conjunction with TAG, held a Community Summit in Amsterdam, the Netherlands. EATAN focuses on supporting the medical and social needs of African migrant populations with HIV, HCV and other…

Read more
Back To Top